Deppe Michael J 4
4 · QUEST DIAGNOSTICS INC · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics (DGX) SVP Michael J. Deppe Receives Stock Award
What Happened Michael J. Deppe, SVP, Corporate Controller & CAO of Quest Diagnostics (DGX), received 1,473 shares as a performance stock award on 2026-03-04 (value $301,759 at $204.86/share). At the same time 750 shares were surrendered back to the company to cover tax withholding obligations (disposition value $153,645). After withholding, Deppe kept a net 723 shares (net value ≈ $148,114).
Key Details
- Transaction dates: 2026-03-04 (reported on Form 4 filed 2026-03-06).
- Award: 1,473 shares @ $204.86 = $301,759 (code A = award/grant).
- Tax withholding: 750 shares disposed @ $204.86 = $153,645 (code F = shares surrendered to issuer for tax withholding).
- Net shares retained: 723 shares (1,473 − 750) with net value ≈ $148,114.
- Footnotes: F1 — stock issued in settlement of a performance stock award under Rule 16b-3(d); F2 — disposition solely to cover tax withholding.
- Timeliness: Filing was submitted within the Form 4 reporting window (timely).
Context This filing reflects settlement of a performance-based equity award, not an open-market purchase or sale. The disposition of shares was a routine cashless withholding to meet tax obligations and is common when awards vest; it should not be interpreted as a voluntary sale indicating sentiment.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-04$204.86/sh+1,473$301,759→ 35,946 total - Tax Payment
Common Stock
[F2]2026-03-04$204.86/sh−750$153,645→ 35,196 total
Footnotes (2)
- [F1]Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
- [F2]Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.